Related Experiment Video

Updated: Jan 24, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update

Sushma Jonna1, Deepa S Subramaniam1

  • 1Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA.

Discovery Medicine
|May 17, 2019
PubMed

Insights

Advances in understanding genetic alterations in non-small cell lung cancer (NSCLC) are leading to new diagnostic and targeted therapy strategies. This report highlights key updates from the IASLC 19th World Conference on lung cancer research.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Diagnostics

Background:

  • Understanding of genetic drivers in non-small cell lung cancer (NSCLC) is rapidly evolving.
  • Many NSCLC molecular subtypes present actionable targets for therapy.
  • Novel diagnostic and therapeutic strategies are under investigation.

Purpose of the Study:

  • To summarize key updates on molecular diagnostics and targeted therapies for NSCLC.
  • To discuss advancements presented at the International Association for Study of Lung Cancer (IASLC) 19th World Conference.
  • To highlight the evolving landscape of actionable genetic alterations in NSCLC.

Main Methods:

  • Review of abstracts and oral presentations from the IASLC 19th World Conference.
  • Synthesis of information on genetic alterations, molecular diagnostics, and targeted therapies in NSCLC.
  • Discussion of emerging trends and research findings.

Main Results:

  • Several presentations focused on the evolving understanding of genetic alterations in NSCLC.
  • New strategies for molecular diagnostics to identify actionable targets were discussed.
  • Updates on targeted therapies for specific molecularly-defined NSCLC subtypes were presented.

Conclusions:

  • The field of NSCLC research is rapidly advancing, with a growing focus on molecularly-defined subtypes.
  • Continued exploration of diagnostic tools and targeted therapies is crucial for improving patient outcomes.
  • The IASLC 19th World Conference showcased significant progress in personalized medicine for NSCLC.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.6K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
663
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K